Correlation between alopecia and alveolar hemorrhage in systemic lupus erythematosus (SLE): Alopecia, which can occur as a manifestation of systemic lupus erythematosus among other systemic diseases, is recognized as one of the clinical features in patients with SLE NICE CKS. Diffuse alveolar hemorrhage (DAH) is a rare but severe pulmonary complication of SLE characterized by bleeding into the alveolar spaces, associated with high morbidity and mortality Xu et al. 2023. In clinical studies, alopecia has been observed more frequently among patients with SLE who develop DAH compared to those who do not, suggesting a possible association of alopecia with more active or severe systemic disease in SLE Xu et al. 2023.
The UK guidelines identify systemic lupus erythematosus as a systemic disease that can cause hair loss (alopecia) among other causes, implicating inflammation-mediated mechanisms NICE CKS. While alopecia itself is not a diagnostic marker of alveolar hemorrhage, its presence in SLE patients may reflect systemic disease activity that predisposes to complications including DAH NICE CKS Xu et al. 2023.
The large retrospective study in Chinese patients with SLE found that alopecia was statistically more frequent in patients with DAH than in those without, alongside other markers of active systemic involvement such as anemia, proteinuria, and interstitial lung disease Xu et al. 2023. However, alopecia was not identified as an independent risk factor for DAH after multivariate analysis, indicating it may be a marker of systemic disease activity rather than a direct cause or predictor of alveolar hemorrhage Xu et al. 2023.
Overall, alopecia in SLE patients likely correlates with systemic inflammation and disease activity that can also contribute to the risk of serious pulmonary complications like DAH, but no direct causal relationship between alopecia and DAH has been established either in clinical guidelines or recent literature NICE CKS Xu et al. 2023. Patients presenting with alopecia and other systemic symptoms should be monitored closely for signs of severe manifestations including alveolar hemorrhage, especially in the presence of anemia, renal involvement, and pulmonary symptoms Xu et al. 2023 NICE CKS.
Key References
- NICE CKS: Female pattern hair loss (female androgenetic alopecia)
- NICE CKS: Alopecia areata
- SmPC: LEMTRADA 12 mg concentrate for solution for infusion
- (Xu et al., 2023): Risk factors of diffuse alveolar hemorrhage in Chinese patients with systemic lupus erythematosus.
- (Hoffmann et al., 2025): Pulmonary Involvement in Autoimmune-Mediated Disease.
- (Barrera-Godínez et al., 2022): Acne Necrotica in a Woman With Systemic Lupus Erythematosus and Systemic Sclerosis.